Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
12/2013
12/04/2013CN103421865A Preparation method for modified cytidine antibiotic
12/04/2013CN103421068A Heteroaryl phosphamide compounds with antiviral activity
12/04/2013CN103421067A Double-target drug for anti-platelet aggregation and applications thereof
12/04/2013CN103421066A Method for extracting putranjivain A
12/04/2013CN103421060A Post-column derivatization preparation method and application of aminoglycosides compound
12/04/2013CN103416223A Method for improving cordycepin output in cordyceps militaris fermentation broth
12/03/2013US8598141 Uridine diphosphate derivatives, compositions and methods for treating neurodegenerative disorders
12/03/2013US8597881 Modified nucleotides
11/2013
11/28/2013WO2013177219A1 D-amino acid compounds for liver disease
11/28/2013WO2013177195A1 3',5'-cyclic phosphate prodrugs for hcv infection
11/28/2013WO2013177188A1 3',5'-cyclic phosphoramidate prodrugs for hcv infection
11/28/2013WO2013176844A1 Compositions and methods for conjugating oligonucleotides
11/28/2013WO2013174962A1 Uracyl spirooxetane nucleosides
11/28/2013US20130317207 Carboxy x rhodamine analogs
11/28/2013US20130316969 Antiviral phosphonate analogs
11/28/2013US20130315868 D-amino acid compounds for liver disease
11/28/2013US20130315867 3',5'-cyclic phosphate prodrugs for hcv infection
11/28/2013US20130315866 3',5'-cyclic phosphoramidate prodrugs for hcv infection
11/28/2013US20130315864 Macrocyclic nucleoside phosphoramidate derivatives
11/28/2013US20130315863 Methods and compositions for treating flaviviridae infections
11/28/2013US20130315862 Methods and compositions for treating hepatitis c virus
11/27/2013CN103408624A Method for synthesizing nucleotide phosphoramidate and nucleotide thio-phosphoramidate
11/26/2013US8592391 Method for therapeutic, clinical and veterinary use poly-ICLC
11/26/2013US8592148 Field-switch sequencing
11/21/2013WO2013173759A2 Macrocyclic nucleoside phosphoramidate derivatives
11/21/2013US20130310551 Nucleoside phosphoramidates
11/21/2013US20130310336 Methods and compositions for treating flaviviruses and pestiviruses
11/21/2013US20130310334 7-Deazapurine Modulators of Histone Methyltransferase, and Methods of Use Thereof
11/21/2013US20130310333 Modulators of Histone Methyltransferase, and Methods of Use Thereof
11/20/2013EP2664621A1 Antiviral agent
11/20/2013CN103403014A O-(replaced benzyl)phosphoramidate and use thereof
11/20/2013CN101429262B Porous resin particle having hydroxy group or primary amino group and production method thereof
11/19/2013US8586304 Method for detecting and quantifying poly(A) RNA and mRNA
11/19/2013CA2572380C Gemcitabine derivatives nanoparticles
11/19/2013CA2446620C Antiviral nucleosides
11/14/2013WO2013168627A1 CRYSTALS OF 5'-O-α-D-GLUCOPYRANOSYLADENOSINE HYDROCHLORIDE AND USE THEREOF
11/14/2013US20130303747 Pyrimidine nucleoside derivatives, synthesis methods and uses thereof for preparing anti-tumor and anti-virus medicaments
11/14/2013US20130303586 Oligonucleotide compositions with enhanced efficiency
11/13/2013CN101932310B Method for preparing nanoparticles based on functional amphiphilic molecules or macromolecules, and the use thereof
11/12/2013US8580949 Enzymatic synthesis of carba-NAD
11/12/2013US8580762 Substituted purine and 7-deazapurine compounds
11/12/2013CA2614639C Pharmaceutical composition for treatment of blood clotting disorder
11/07/2013WO2013166155A1 Novel tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotides
11/07/2013WO2013166121A1 Novel tetragalnac containing conjugates and methods for delivery of oligonucleotides
11/07/2013WO2013165266A1 Method for protecting hydroxyl, amine or thiol functional groups with tetraisopropydisilane and the corresponding protected compounds
11/07/2013US20130296542 CRYSTALLINE PHASES OF 5,6-DICHLORO-2-(ISOPROPYLAMINO)-(1-ß-L-RIBOFURANOSYL)-1H-BENZIMIDAZOLE
11/06/2013EP2660246A1 Compound, nucleic acid, method for producing nucleic acid, and kit for producing nucleic acid
11/06/2013EP2658863A1 Novel antibacterial compounds
11/06/2013EP2658862A1 Spiroannulated nucleosides and process for the preparation thereof
11/06/2013EP2658857A2 Substituted purine nucleosides, phosphoroamidate and phosphorodiamidate derivatives for treatment of viral infections
11/06/2013EP2471804B1 Diadenosine antibacterial compounds
11/06/2013CN103382212A 5'-bit modified puromycin compound, and preparation method and applications thereof
11/06/2013CN101979397B HCV nucleoside inhibitor
11/05/2013US8575331 Synthesis and use of 2′-substituted-N6-modified nucleosides
11/05/2013US8575128 Methods for transdifferentiation of body tissues
11/05/2013US8575127 Antithrombotic diadenosine tetraphosphates and related analogs
11/05/2013US8575119 2′-chloroacetylenyl substituted nucleoside derivatives
11/05/2013CA2735079C Preparation of alkyl-substituted 2-deoxy-2-fluoro-d-ribofuranosyl pyrimidines and purines and their derivatives
10/2013
10/31/2013US20130289266 Spiroannulated Nucleosides and Process for the Preparation Thereof
10/31/2013US20130289263 Compound, nucleic acid, method for producing nucleic acid, and kit for producing nucleic acid
10/31/2013US20130288997 Nucleoside phosphoramidates
10/30/2013EP2657246A1 Modulator of activity of adenylate cyclase
10/30/2013EP2655392A1 Cyclic nucleotide analogs
10/30/2013CN103374053A Method for extracting cyclic adenosine monophosphate from red dates by ultrasonic waves
10/30/2013CN103374052A Capecitabine crystal form and preparation method thereof
10/30/2013CN101605457B P-toluene sulfonic acid salt of 5-amino-3-(2'-o-acetyl-3'-deoxy-ss-d-ribofuranosyl)-3h-thiazole [4, 5-d] pyrimidine-2-one and methods for preparation
10/29/2013US8569478 Modified 4′-nucleosides as antiviral agents
10/29/2013US8569260 N-pyrazole A2A receptor agonists
10/29/2013US8569259 Adenosine analogs and their use
10/29/2013US8568742 Methods and compositions involving immunostimulatory oligodeoxynucleotides
10/24/2013US20130281687 Methods of preparing substituted nucleotide analogs
10/24/2013US20130281682 Synthesis of phosphitylated compounds using a quaternary heterocyclic activator
10/23/2013CN103360448A Single crystal form of metacavir ethanol solvent compound and preparation method thereof
10/22/2013US8563530 Purine nucleoside phosphoramidate
10/22/2013US8563526 Triazole derivatives, their preparation and their application in therapeutics
10/17/2013WO2013154799A1 Tricyclic nucleosides and oligomeric compounds prepared therefrom
10/17/2013WO2013154798A1 Tricyclic nucleic acid analogs
10/17/2013WO2007083173A3 Mononucleotides and mononucleosides for use in therapy
10/17/2013US20130274459 Methods for isolating crystalline form i of 5-azacytidine
10/16/2013CN101240001B 2'-fluoro nucleotide
10/15/2013CA2567700C 3-triazolyl-galactoside inhibitors of galectins
10/15/2013CA2533926C Methods and compositions for producing antigenic responses
10/10/2013WO2013151033A1 C-glycoside derivative having a spiro ring
10/10/2013WO2013150902A1 Method for producing 5'-terminal-phosphorylated oligodeoxynucleotide by cleaving oligodeoxynucleotide containing non-naturally-occurring nucleotide
10/10/2013WO2013068850A8 PROCESS FOR THE PREPARATION OF β-C-ARYL GLUCOSIDES
10/10/2013US20130266538 Solid Forms of a Thiophosphoramidate Nucleotide Prodrug
10/10/2013US20130264207 Dna sequencing by synthesis using modified nucleotides and nanopore detection
10/09/2013EP2647644A1 2'-o-modified rna
10/09/2013EP2647382A1 Compositions and methods for treating epithelial and retinal tissue diseases
10/09/2013EP2646456A1 Process for the preparation of morpholinyl anthracycline derivatives
10/09/2013EP2646455A2 Modulators of histone methyltransferase, and methods of use thereof
10/09/2013EP2646454A2 7-deazapurine modulators of histone methyltransferase, and methods of use thereof
10/09/2013EP2646453A1 Compounds
10/09/2013CN103347871A Synthesis of FLG
10/09/2013CN103347542A 免疫刺激性寡核苷酸 Immunostimulatory oligonucleotides
10/09/2013CN103342727A Synthetic method of 2-methoxyl adenosine
10/08/2013US8552054 Anticancer agents, viricides, psychological disorders
10/08/2013US8552013 Heterocyclic compounds based on N6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds
10/08/2013US8551973 Nucleoside analogs
10/08/2013US8551966 Chemical compounds
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 ... 201